Global Health

Namibia's president says disparate global rates of vaccination represent "COVID apartheid." When you compare percent of people vaccinated in the most populous countries, you can understand his ire.

India is grappling with shortages of hospital beds, oxygen and vaccines amid a sharp spike in COVID-19 cases. Scientists are scrambling to sequence new variants.

For decades, the U.S. has spent many millions hunting down viruses in hope of stopping a pandemic. Yet the efforts failed. A group of researchers thinks there's a better strategy for the future.

While emphasizing that the risk is low, the health agency said there should be a warning about the rare condition included in the product information for the vaccine.

The European Medicines Agency says there is a possible link between the J&J vaccine and rare blood clotting. It says a warning should be added to the label, but says benefits outweigh the risks.

The 18-year-old gave her point of view at a World Health Organization press conference, saying it's "unethical" to vaccinate young people in wealthy countries ahead of health workers in poor places.

Australia and New Zealand have launched one of the world's first "travel bubbles" between countries. People traveling between the two now no longer have to quarantine upon landing.

Health workers from the West couldn't help out in other countries due to lockdowns and restrictions. So they turned to help at home. But what is their role in lower resource countries moving forward?

The largest number of deaths have come in the United States, Brazil, Mexico, India and the United Kingdom. The pandemic death toll reached 1 million in September 2020 and 2 million in January.

People are using social media to proclaim joy at getting a jab. And that's not just boasting. Even in a world of vaccine inequity, these celebratory tweets and videos carry a vital message.

In the U.S., more than 1 out of 5 residents is fully vaccinated against COVID-19. But elsewhere in the world, vaccination rates are much lower. Some poor nations have yet to receive a single dose.

The U.S. Food and Drug Administration's decision to temporarily halt the use of the Johnson & Johnson COVID-19 vaccine is having ramifications globally.